PD-1 is a coinhibitory molecule in activated T cells and a well-known marker of CD8+ T cell exhaustion, a condition that is characterized by impaired effector function and is frequently observed in the setting of both chronic viral infection and malignant tumors (33, 34). The gene discussed is CD8A; the disease is cancer.